A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder

✍ Scribed by Christopher Chapple; William Steers; Peggy Norton; Richard Millard; Georg Kralidis; Karin Glavind; Paul Abrams

• Book ID: 109051754
• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 237 KB
• Volume: 95
• Category: Article
• ISSN: 1464-4096
• DOI: 10.1111/j.1464-410x.2005.05454.x